Xxera/openscience/retractions

Record #18661

Cost-utility analysis of trastuzumab combined with Docetaxel for patients with HER-2 positive metastatic breast cancer - real world claim data

Henry W C Leung, Agnes L F Chan, Shyh Yau Wang

Journal

Journal of Oncology Pharmacy Practice

Publisher

SAGE Publications

Original paper date

Jan 1, 2018

Original DOI

10.1177/1078155218755548

Country

🇹🇼 Taiwan

Institution

Department of Radiation Oncology, An Nan Hospital, China Medical University, Tainan, Taiwan · Department of Pharmacy, An-Nan Hospital, China Medical University, Tainan, Taiwan · Department of Radiology, An-Nan Hospital, China Medical University, Tainan, Taiwan

Open access

No

Article type

Research Article

Broad categories

(B/T) Business - Economics (HSC) Medicine - Oncology (HSC) Medicine - Pharmacology

Citation lifecycle

How this paper is being cited

Pre-retraction

0

Same day

0

Post-retraction

2

% post-retraction

100.0%

~0.0 citations/yr before retraction · ~0.2 citations/yr after

— citing papers

Who is still citing this work

Loading…